People with Cushing’s disease who are treated with Isturisa (osilodrostat) should be monitored for the possibility of developing…
Articles by Marisa Wexler, MS
Thyrotoxicosis, or abnormally high levels of thyroid hormones in the body, is a rare complication that can occur in people…
Measuring the levels of the RNA molecule that provides instructions to make a protein called FKBP5 could be useful for…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
The U.S. Patent and Trademark Office has issued a new patent to Strongbridge Biopharma that covers a method of…
Xeris Pharmaceuticals and Strongbridge Biopharma have entered an agreement in which Xeris will acquire Strongbridge, forming a new…
Sparrow Pharmaceuticals is planning to launch a Phase 2 clinical trial to assess the safety and effectiveness of its…
For people with Cushing’s disease whose pituitary tumor cannot be identified, removal of one-third of the pituitary gland followed…
The U.S. Food and Drug Administration (FDA) is reviewing an application from Strongbridge Biopharma seeking the approval of…
Chronic insomnia can be a sign of Cushing’s syndrome, and doctors need be aware of this possibility, according to a…